Department of Medicine, Division of Critical Care Medicine, Division of Gastroenterology, McMaster University, Hamilton, Ontario, Canada.
Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
Curr Opin Crit Care. 2023 Apr 1;29(2):138-144. doi: 10.1097/MCC.0000000000001024. Epub 2023 Feb 22.
In this paper, we review the current evidence with respect to definitions, risk factors, and outcomes of diarrhea in the critically ill and highlight research gaps in the literature.
Definitions of diarrhea in the intensive care unit (ICU) include the World Health Organization quantified as >3 liquid bowel movements per day and the Bristol Stool Chart score of 7. Diarrhea incidence is 37.7-73.8% and varies based on definition applied. Clostridioides difficile associated diarrhea (CDAD) is uncommon with an incidence of 2.2%. Risk factors for diarrhea include total number of antibiotics, enteral nutrition, and suppository use. The composition of enteral nutrition including high osmolarity and high fiber feeds contributed to diarrhea occurrence. Opiates decrease diarrhea incidence whereas probiotics have no effect on the incidence or duration of diarrhea. Outcomes of diarrhea include increased length of stay in the ICU and hospital, however its impact on mortality is unclear.
Diarrhea remains a common problem in clinical practice and attention must be paid to modifiable risk factors. Further research is needed on interventions to decrease its burden.
本文综述了目前关于危重症患者腹泻的定义、危险因素和结局的证据,并强调了文献中的研究空白。
重症监护病房(ICU)腹泻的定义包括世界卫生组织规定的每天>3 次稀便和布里斯托大便图表评分 7 分。腹泻的发生率为 37.7-73.8%,具体取决于所应用的定义。艰难梭菌相关性腹泻(CDAD)并不常见,发病率为 2.2%。腹泻的危险因素包括抗生素的总数量、肠内营养和栓剂的使用。肠内营养的组成,包括高渗透压和高纤维饲料,导致了腹泻的发生。阿片类药物可降低腹泻的发生率,而益生菌对腹泻的发生率或持续时间没有影响。腹泻的结局包括 ICU 和住院时间延长,但对死亡率的影响尚不清楚。
腹泻在临床实践中仍然是一个常见的问题,必须注意可改变的危险因素。需要进一步研究干预措施以减轻腹泻的负担。